Literature DB >> 25800585

Muscle diffusion of liposomal amphotericin B and posaconazole in critically ill burn patients receiving continuous hemodialysis.

Quentin Ressaire1, Christophe Padoin, Marc Chaouat, Veronique Maurel, Alexandre Alanio, Axelle Ferry, Sabri Soussi, Mourad Benyamina, Blandine Denis, Maurice Mimoun, Alexandre Mebazaa, Matthieu Legrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25800585     DOI： 10.1007/s00134-015-3754-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection.

Authors:  A J Ullmann; O A Cornely; A Burchardt; R Hachem; D P Kontoyiannis; K Töpelt; R Courtney; D Wexler; G Krishna; M Martinho; G Corcoran; I Raad
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 2.  Epidemiology and clinical manifestations of mucormycosis.

Authors:  George Petrikkos; Anna Skiada; Olivier Lortholary; Emmanuel Roilides; Thomas J Walsh; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

Review 3.  Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring.

Authors:  Michael J Dolton; John E Ray; Deborah Marriott; Andrew J McLachlan
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

4.  Posaconazole pharmacokinetics, safety, and tolerability in subjects with varying degrees of chronic renal disease.

Authors:  R Courtney; A Sansone; W Smith; T Marbury; P Statkevich; M Martinho; M Laughlin; S Swan
Journal:  J Clin Pharmacol       Date:  2005-02       Impact factor: 3.126

Review 5.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132
  5 in total
  2 in total

Review 1.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

2.  Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

Authors:  Fekade B Sime; Janine Stuart; Jenie Butler; Therese Starr; Steven C Wallis; Saurabh Pandey; Jeffrey Lipman; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.